Study of GenSci134 for children with idiopathic short stature
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 and 12 years old (depending on the part of the study).
- Your child has been diagnosed with idiopathic short stature (short height with no clear medical cause).
- Your child has never been treated with growth hormone or IGF-1 therapy.
- Your child does not have other conditions known to cause short stature, such as Turner syndrome, Noonan syndrome, or growth hormone deficiency.
- Your child's bone age is not more than 1 year behind their actual age (for the second study phase).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This study looks at your child’s growth history and performs genetic testing to better understand why some children are very short. It may help researchers identify possible underlying causes and improve care, using blood samples from the child and both parents.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
Hear when a new Idiopathic Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.